Table 4 Target Organ damage in Metabolic Syndrome

Vascular

Carotid IMT men average (mm)

0.75 ± 0.12

0.76 ± 0.12

0.00

-0.01

to

0.02

0.40

Carotid IMT men average ≥ 90 mm, n (%)

6 (13.60)

5 (11.40)

-2.20

-16

to

11

0.62

Carotid IMT maximum average (mm)

0.93 ± 0.15

0.93 ± 0.15

0.00

-0.02

to

0.03

0.63

Carotid IMT maximum average ≥ 90 mm, n (%)

25 (56.80)

23 (52.30)

-4.50

-24

to

18

0.39

Plaques, n (%)

3 (6.80)

3 (6.90)

0.1

-10

to

11

1.00

ABI

1.10 ± 0.10

1.15 ± 0.09

0.05

0.01

to

0.09

0.03

TOD ABI, n (%)

1(2.30)

2 (4.70)

2.40

-5

to

10

0.03

PWV, (m/s)

9.34 ± 2.69

8.57 ± 2.22

-0.77

-1.50

to

0.07

0.04

PWV ≥ 12 m/s, n (%)

7 (15.90)

2 (4.70)

-11.20

-24

to

12

0.75

TOD Vascular, n (%)

11 (25.00)

6 (14.00)

-11

-27

to

54

0.06

Renal

GFR CKD-EPI (mL/min/1.73 m2)

88.57 ± 13.89

87.26 ± 16.03

-1.31

-5.15

to

2.58

0.50

TOD GFR CKD-EPI ≤ 60 mL/min/1.73 m2, n(/%)

0 (0.00)

3 (7.00)

7

-1

to

15

0.25

Albumin/creatinine (mg/g)

17.31 ± 39.04

28.89 ± 133.82

11.58

-30.36

to

55.92

0.55

TOD Albumin/creatinine (mg/g), n (%)

7 (16.30)

1 (2.40)

13.90

-25

to

-2

0.06

TOD Renal n (%)

7 (16.30)

5 (11.90)

-4.40

-18

to

10

1.00

Heart

Cornell VDP (mmms)

1486.64 ± 457.67

1661.89 ± 536.983

184.22

62.28

to

306.15

0.01

TOD Cornell VDP (mmms) patologico, n(%)

1 (2.30)

4 (9.30)

7

-3

to

17

0.25

TOD global, n (%)

1 (2.30)

4 (9.30)

7

-3

to

17

0.25